ArticleArchives of Razi Institute2025
Polyherbal Therapy Restores Sensorimotor Function in Chronic Stress-induced Oxidative Damage.
Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Stress is a mental strain resulting from adverse circumstances. One of the main predictors of the onset of a major depressive episode is chronic, mild stress. Oxidative stress is caused by an imbalance between the production of reactive oxygen species (ROS) and the body's ability to remove them through antioxidant defenses. This imbalance in sensorimotor function may have a substantial effect on both motor output and sensory processing. This study evaluates the impact of polyherbal formulation (PHF) on sensorimotor function under unpredicted mild chronic stress (UCMS). Materials & Methods: A total of 25 adult Wistar rats (120-150 g) were divided at random into five groups consisting of five animals each. Rats in group 1 received 1 mL of distilled water each; group 2 was exposed to UCMS; group 3 was exposed to UCMS and treated with imipramine (25 mg/kg); groups 4 and 5 were exposed to UCMS and received PHF extract (250 mg/kg and 750 mg/kg), respectively. All groups received oral treatment once daily for 21 days. Animals were subjected to a beam-walking task to assess sensorimotor function following 21 days of treatment. Following behavioral tests, the animals' cervical dislocation was followed by histological examination of the cerebellum and biochemical estimation of the activities of corticosterone, malondialdehyde (MDA), and catalase (CAT). Results: Using Lorke's method, the LD Conclusion: Conclusively, treatment with PHF enhanced sensorimotor functions and mitigated oxidative damage due to stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.